All About the FDA’s “Drug Trials Snapshots” Database, Demographic Data About U.S. Trials
From an FDA Announcement:
Have you ever wondered if someone like you participated in the clinical trials for a new drug? If you have, you’re not alone.
That’s why FDA is making demographic information from clinical trials, such as the inclusion of women and minority groups, more easily available to consumers through its online Drug Trials Snapshots database. This section of the FDA website is written in an easy-to-read format so you can see who took part in research studies for new drugs by sex, race, and age.
Snapshots also help people understand if there are any differences in the benefits or side effects of a new drug between men and women, and among patients of different races and ages.
Through Drug Trials Snapshots, FDA is addressing concerns raised by advocacy groups and the public, including important issues such as tracking information about how many women and minorities participate in drug trials.
It used to be hard for consumers to find details about how many people were enrolled in drug trials – as well as information about their race, sex, and age.
Drug Trials Snapshots provide more information than is found in the patient prescribing information (or drug label) – but keep in mind that they don’t replace it or provide prescribing information.
Direct to Drug Trials Snapshots
About Gary Price
Gary Price (firstname.lastname@example.org) is a librarian, writer, consultant, and frequent conference speaker based in the Washington D.C. metro area. He earned his MLIS degree from Wayne State University in Detroit. Price has won several awards including the SLA Innovations in Technology Award and Alumnus of the Year from the Wayne St. University Library and Information Science Program. From 2006-2009 he was Director of Online Information Services at Ask.com. Gary is also the co-founder of infoDJ an innovation research consultancy supporting corporate product and business model teams with just-in-time fact and insight finding.